Legal Proceedings Report • Sep 3, 2020
Legal Proceedings Report
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 8607X
Kropz PLC
03 September 2020
3 September 2020
Kropz Plc
("Kropz" or the "Company")
Elandsfontein Update regarding Water Tribunal ("Tribunal")
Kropz plc (AIM: KRPZ) advises that, further to the announcement on 20 August 2020, the appeal hearing against Elandsfontein's valid integrated water use licence ("WUL") which was due to reconvene today, has been postponed.
The Company will provide an update on the final hearing dates once it has been notified by the Tribunal.
Pending the Tribunal's decision, there is no legal impediment to the continuation of the water use activities authorised in the WUL.
For further information visit www.kropz.com or contact:
| Kropz Plc | |
| Mark Summers (CEO) | +27 (0)79744 8708 |
| Grant Thornton UK LLP | Nominated Adviser |
| Samantha Harrison Niall McDonald |
+44 (0) 20 7383 5100 |
| Hannam & Partners | Joint Broker |
| Andrew Chubb Ernest Bell |
+44 (0)20 7907 8500 |
| Mirabaud Securities Ltd | Joint Broker |
| Rory Scott Edward Haig-Thomas |
+44 (0)20 3167 7220 +44 (0)20 3167 7222 |
| Tavistock | Financial PR & IR (UK) |
| Emily Moss Jos Simson Oliver Lamb |
+44 (0) 207 920 3150 [email protected] |
| R&A Strategic Communications | PR (South Africa) |
| James Duncan | +27 (0)11 880 3924 [email protected] |
About Kropz Plc
Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate mining project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.
-ENDS-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFLFVSADIFIII
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.